Research Article
QbD based approach to RP-HPLC method development and validation of Bupivacaine hydrochloride in bulk and in-house developed nanostructured lipid carriers
Abstract
The present study describes the principles of systematic Quality by design (QbD) approach for the development of RP-HPLC method for the quantification of Bupivacaine hydrochloride (BUP) in bulk and in-house developed nanostructured lipid carriers (NLCs). Initially analytical target profile (ATP), and critical analytical attributes (CAAs) were identified. Primary assessment studies were checked using Plackett-Burman Design. Further optimization studies were performed by applying Box-Behnken design. The Shimadzu C-18 column (250mm x 4.6mm i.d., 5μm particle size) was utilized for reversed-phase chromatographic separation with a mobile phase comprising a mixture of acetonitrile (ACN) and 0.1% ortho phosphoric acid (OPA) (pH 2.04) in 69.45:30.55 (% v/v). The flow rate was 0.805mL/min at a λ max of 214 nm and an injection volume of 12μL. The new developed method was validated according to the guidelines given by International Conference on Harmonization which revealed linearity between 25 to 80μg/ml and r2 = 0.999. The result of % RSD was 0.38 and 0.44 respectively for high degree of intraday and interday precision. As per the new method the LOD and LOQ is 0.900μg/ml and 2.72μg/ml, respectively. Further the validated method was also applied for the estimation of BUP in NLCs formulation, which showed no interference of any formulation excipients. The studies demonstrated that the new method is rapid, simple, selective, and reproducible for the estimation of pure drug and in-house developed NLCs.
References
- [1] Yaocun Y, Dandan Z, Qiuwen Y. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Biomed. Pharmacother. 2018; 98:813–820. https://doi.org/10.1016/j.biopha.2017.12.103
- [2] Government of India, Ministry of Health and Family Welfare, Indian Pharmacopeia. The Indian Pharmacopeia Commission Ghaziabad, 2010; Volume 2; pp. 933-934.
- [3] Taylor A., G. McLeod G.; Basic pharmacology of local anaesthetics. BJA Educ. 2020; 20: 34-41. https://doi.org/10.1016/j.bjae.2019.10.002
- [4] Rodrigues da Silva GH, Geronimo G, Ribeiro LNM, Guilherme VA, de Moura LD, Bombeiro AL, Oliveira JD, Breitkreitz MC, de Paula E. Injectable in situ forming nanogel: A hybrid Alginate-NLC formulation extends bupivacaine anesthetic effect. Mater. Sci. Eng. C. 2020; 109: 110608. https://doi.org/10.1016/j.msec.2019.110608
- [5] Ribeiro LNM, Franz-Montan M, Breitkreitz MC, Rodrigues da Silva GH, Castro SR, Guilherme VA, de Araújo DR, de Paula E. Nanohybrid hydrogels designed for transbuccal anesthesia. Int J Nanomedicine. 2018; 13: 6453-6463. https://doi.org/10.2147/IJN.S180080
- [6] Chen H., Wang Y., Zhai Y., Zhai G., Wang Z., Liu J. Development of a ropivacaine-loaded nanostructured lipid carrier formulation for transdermal delivery. Colloids Surf. A Physicochem. Eng. Asp. 2015; 465: 130-136. https://doi.org/10.1016/j.colsurfa.2014.10.046
- [7] Mendes A.I., Silva A.C., CatitaJ. A.M., Cerqueira F., Gabriel C., Lopes C.M. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: Improving antifungal activity, Colloids Surf. B. 2013; 111:755-763. https://doi.org/10.1016/j.colsurfb.2013.05.041
- [8] Shah NV, Seth AK, Balaraman R, Aundhia CJ, Maheshwari RA, Parmar GR. Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study. J Adv Res. 2016; 7: 423-34. https://doi.org/10.1016/j.jare.2016.03.002
- [9] Andreia C. Spectrophotometric method for determination of bupivacaine hydrochloride in pharmaceutical preparations. Eur. Chem. Bull. 2012; 2: 554-557.
- [10] Babu CH. M., Jagathi V., Rajesh V., Rao P. B., Basha S. M. and Rao G. D. RP-HPLC method for the estimation of bupivacaine HCl in pharmaceutical dosage forms. Int. J. Chem. Sci. 2011; 9: 197-204.
- [11] Piekarski M, Jelin'ska A, Szymczak K. Development and validation of an HPLC method to determine the stability of fentanyl citrate and bupivacaine hydrochloride mixtures in infusion Solutions. Eur J Hosp Pharm. 2012; 19: 447–451. http://dx.doi.org/10.1136/ejhpharm-2012-000088
- [12] Macorigh C, Guibbert V, Casanova M, Haenni C. Stability study of hydromorphone and bupivacaine mixture by HPLC-UV. Eur J Hosp Pharm. 2020; 27: 95–99. http://dx.doi.org/10.1136/ejhpharm-2018-001553
- [13] Muni K. A, Ramachandraiah C, Srinivas M, Devanna N. Development of rapid, sensitive, High Performance Liquid Chromatography -Tandem Mass Spectrometry (HPLC-MS/MS) assay for the simultaneous determination of bupivacaine and procaine in human plasma. JETIR 2018; 5: 701-716.
- [14] Kamlesh M. P., Dr. Ashaben D. P. A comparative study for force degradation of three local anesthetic drugs bupivacaine, ropivacaine, mepivacaine and quantitative analysis of their degraded products by newly developed and validation HPLC-UV and LC-MS method. Int. J. Curr. Res. 2017; 9: 53036-53043.
- [15] Dinçel A, Kızıltunç PB, Atilla H, Onur F, Demirel S. Chromatographic Analysis of Aqueous Humor of Bupivacaine in Different Administration Approaches, J. Chromatogr. Sci. 2022; bmac066. https://doi.org/10.1093/chromsci/bmac066
- [16] Prathyusha PCHGS, Shanmugasundaram P., Naidu P. Y. and Sanjeev S. Development and validation of stability indicating UPLC assay method for bupivacaine in pharmaceutical formulation. J. Chem. Pharm. 2012; 4: 4702-4709.
- [17] Siddareddy K., Reddy M. A. U., Suresh B., Sreeramulu J., Development and validation of analytical method for simultaneous estimation of bupivacaine and meloxicam in human plasma using UPLC-MS/MS. Pharm Methods. 2018;9: 2-8.
- [18] Yaocun Y., Dandan Z., Qiuwen Y. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Biomed. Pharmacother. 2018; 98: 813–820. https://doi.org/10.1016/j.biopha.2017.12.103
- [19] Krull I, Swartz M, Turpin J, Lukulay P, Verseput R. A quality-by-design methodology for rapid LC method development, part I. Liq Chroma Gas Chroma N Am 2008;26:1190–1197.
- [20] Barrawaz Aateka Y., Abubakar S. B., Jaiprakash N. S., Shahajan S. B.& Sana S. S. QbD-Based Development and Validation of an Efficient RP-HPLC Method for Estimation of Abiraterone Acetate in Bulk, Tablet, and In-House-Developed Nano-Formulation. Anal. Chem. Lett. 2021; 11: 112-130. https://doi.org/10.1080/22297928.2021.1888794
- [21] Beg, S., Sharma, G., Katare, O.P., Lohan, S., Singh, B. Development and validation of stability-indicating liquid chromatographic method for estimating olmesartan medoxomil using quality by design. J. Chromatogr. Sci. 2015; 53: 1048-59. https://doi.org/10.1093/chromsci/bmu165
- [22] Sandhu, P.S., Beg, S., Katare, O.P., Singh, B. QbD-Driven Development and Validation of a HPLC Method for Estimation of Tamoxifen Citrate with Improved Performance. J. Chromatogr. Sci. 2016; 54: 1373-1384. https://doi.org/10.1093/chromsci/bmw090
- [23] International Conference on Harmonization (ICH). Validation of analytical procedures: text and methodology Q2(R1),2005.
- [24] Chen-yu G, Chun-fen Y, Qi-lu L, Qi T, Yan-wei X, Wei-na L, Guang-xi Z. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm. 2012; 430: 292-8. https://doi.org/10.1016/j.ijpharm.2012.03.042
There are 24 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Pharmacology and Pharmaceutical Sciences (Other) |
| Journal Section | Articles |
| Authors | |
| Publication Date | June 28, 2025 |
| Published in Issue | Year 2023 Volume: 27 Issue: 5 |